The results of a meta-analysis including 33 studies show that GLP1RAs have a modest, albeit significant, effect on lipid profile which is independent of their effect on weight reduction
Semaglutide is safe for diverse patient populations and treatment durations, but it still has some side effects to be aware of: Anxiety Blurred vision Constipation Diarrhea Faster heartbeat Fatigue Fever Headaches Lightheadedness Nausea Shakiness or weakness Stomach pain Sweating Vomiting Yellow skin or eyes In one study, about one third of patients reported some side effects, though many were manageable
They serve different purposes but both affect the digestive environment
The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy
This makes it an excellent option for those with a higher risk due to obesity and related conditions
The gap between doing it right and doing it wrong is visible: a clear solution means intact peptide structure